4//SEC Filing
CORE LABORATORIES N V 4
Accession 0001000229-15-000012
CIK 0001000229operating
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:06 PM ET
Size
8.7 KB
Accession
0001000229-15-000012
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Shares
2014-12-31+3,000→ 43,205 total - Exercise/Conversion
Restricted Performance Shares
2014-12-31−3,000→ 0 totalExercise: $0.00→ Common Shares (3,000 underlying) - Tax Payment
Common Shares
2014-12-31−821→ 42,384 total
Footnotes (1)
- [F1]The shares vesting were awarded as restricted performance shares in February 2012. As reported in the Form 4 filing on February 17, 2012 at the time the award was made, "The Restricted Performance Sharesvest based on the Company's return on invested capital for the period that began on January 1, 2012 and ends on December 31, 2014 (the "performance period") as follows. If the Company's return on investedcapital at the end of the performance period is in the top decile of the return on invested capital of the Company's peers as published by Bloomberg, then the Restricted Performance Shares will fully vest. If thiscriteria is not met, then no shares shall vest and the award will be forfeited." The performance criteria and all requirements for vesting have been met and thus the shares fully vested on December 31, 2014, at the conclusion of the performance period
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001000229
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:06 PM ET
- Size
- 8.7 KB